apyrase and Hepatitis-B

apyrase has been researched along with Hepatitis-B* in 1 studies

Other Studies

1 other study(ies) available for apyrase and Hepatitis-B

ArticleYear
Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection.
    Journal of leukocyte biology, 2015, Volume: 98, Issue:6

    Hepatitis B virus is a major cause of chronic liver inflammation worldwide. Innate and adaptive immune responses work together to restrain or eliminate hepatitis B virus in the liver. Compromised or failed adaptive immune response results in persistent virus replication and spread. How to promote antiviral immunity is a research focus for hepatitis B virus prevention and therapy. In this study, we investigated the role of macrophages in the regulation of antiviral immunity. We found that F4/80(+)CD206(+)CD80(lo/+) macrophages were a particular hepatic macrophage subset that expressed amphiregulin in our mouse hepatitis B virus infection model. CD206(+) macrophage-derived amphiregulin promoted the immunosuppressive activity of intrahepatic regulatory T cells, demonstrated by higher expression of CTLA-4, ICOS, and CD39, as well as stronger inhibition of antiviral function of CD8(+) T cells. Amphiregulin-neutralizing antibody diminished the effect of CD206(+) macrophages on regulatory T cells. In addition, we found that CD206(+) macrophage-derived amphiregulin activated mammalian target of rapamycin signaling in regulatory T cells, and this mammalian target of rapamycin activation was essential for promotion of regulatory T cell activity by CD206(+) macrophages. Adoptive transfer of CD206(+) macrophages into hepatitis B virus-infected mice increased cytoplasmic hepatitis B virus DNA in hepatocytes and also increased serum hepatitis B surface antigen. The antiviral activity of CD8(+) T cells was decreased after macrophage transfer. Therefore, our research indicated that amphiregulin produced by CD206(+) macrophages plays an important role in modulating regulatory T cell function and subsequently restrains the antiviral activity of CD8(+) T cells. Our study offers new insights into the immunomodulation in hepatitis B virus infection.

    Topics: Amphiregulin; Animals; Antigens, CD; Apyrase; CD8-Positive T-Lymphocytes; CTLA-4 Antigen; Disease Models, Animal; EGF Family of Proteins; Gene Expression Regulation; Hepatitis B; Hepatitis B virus; Immune Tolerance; Inducible T-Cell Co-Stimulator Protein; Lectins, C-Type; Liver; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Mice; Receptors, Cell Surface; T-Lymphocytes, Regulatory; TOR Serine-Threonine Kinases

2015